INACTIVE/DISSOLVED
Address
Excalibur Fund Managers Ltd
Berkeley Square
Berkeley Square House
London
W1J 6BD
United Kingdom
Phone
Industry
VCID: 32746
Profile
Corporate information
Official name
Excalibur Fund Managers Ltd
Registration country
Official name
Excalibur Fund Managers Ltd
Registration country
Investment activity status
Not investing
Funds managed
| Fund | Type | Vintage |
|---|---|---|
| Merlin Biosciences Fund III LP | Venture | 2003 |
Investments
Selected investments
| Company | Country | Notes | ||
|---|---|---|---|---|
|
DestinationSkin Ltd Skin treatment and hair removal. |
United Kingdom | N/A |
|
|
|
Amura Ltd A structure-based drug discovery business specialising in diseases such as osteoporosis, osteoarthritis, bone metasta. Secondary sale in February 2005 |
United Kingdom | N/A |
|
|
|
EpiCept Inc Topical pain management. IPO in January 2006. |
United States | N/A |
|
|
|
ReNeuron Group PLC Treatments for neurological disorders. IPO in August 2005 |
United Kingdom | N/A |
|
|
|
Biovex Inc Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease. |
United States | N/A Active |
|
|
|
Energist Ltd Manufactures and markets lasers and light-based systems for hair removal and aesthetic skin treatments, serving both the medical and beauty sectors. |
United Kingdom | N/A |
|
|
|
Ardana PLC Drugs for reproductive disorders and hormone sensitive cancers. IPO in March 2005. |
United Kingdom | N/A |
|
|
|
Intercytex Group PLC A UK Regenerative Medicine Company product and services. IPO in February 2006. Presently known as Regenerative Medicine Assets Ltd. |
United Kingdom | N/A |
|
|
|
Santhera Pharmaceuticals AG Small molecule therapeutics for neuromuscular and metabolic diseases. IPO in November 2006. |
Switzerland | N/A |
|
|
|
Lab21 Ltd |
United Kingdom | N/A |
|
|
|
Ark Therapeutics Group PLC Gene-based drugs for vascular and circulatory diseases and cancer. IPO in March 2004. |
United Kingdom | N/A |
|
|
|
LiDCO Group PLC Researches, develops, manufactures and sells innovative medical devices. IPO in June 2004. |
United Kingdom | N/A |
|
|
|
Sosei Co Ltd Identifying new uses for established drugs. Arakis merged with Sosei Co in August 2005. |
Japan | N/A |
|
|
|
PIramed Pharma Ltd Oncology Therapeutics. Acquired by Roche in April 2008. |
United Kingdom | N/A |
|
|
|
Biovertis AG Hospital-acquired infections; respiratory tract infections; urinary tract infections. Acquired Morphochem AG in March 2006. |
Austria | N/A |
|
|
|
Neurotech Pharmaceuticals Inc Cell-based drugs for diseases of the eye. |
United States | N/A |
|
|
|
Vectura Group PLC Drug formulations and devices for respiratory diseases. IPO in July 2004. |
United Kingdom | N/A |
|
|
|
Plethora Solutions Holdings PLC Discovering and developing urological products. IPO in March 2005. |
United Kingdom | N/A |
|
|
|
Cambridge Biotechnology Ltd Small molecule drugs for pain and obesity. Aquired by Biovitrum AB in April 2005. |
United Kingdom | N/A |
|
|
|
Noxxon Pharma AG Mirror image oligonucleotide drugs. |
Germany | N/A |